You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

List of Excipients in API ubrogepant

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing ubrogepant

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Allergan Inc	UBRELVY	ubrogepant	0023-6498	CELLULOSE, MICROCRYSTALLINE	2035-01-30
Allergan Inc	UBRELVY	ubrogepant	0023-6498	COPOVIDONE K25-31	2035-01-30
Allergan Inc	UBRELVY	ubrogepant	0023-6498	CROSCARMELLOSE SODIUM	2035-01-30
Allergan Inc	UBRELVY	ubrogepant	0023-6498	MANNITOL	2035-01-30
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for ubrogepant

Excipient focus: CELLULOSE, MICROCRYSTALLINE

ubrogepant drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Allergan Inc	ubrogepant	0023-6498
>Company	>Ingredient	>NDC

ubrogepant drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: COPOVIDONE K25-31

ubrogepant drug variants containing COPOVIDONE K25-31

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Allergan Inc	ubrogepant	0023-6498
>Company	>Ingredient	>NDC

ubrogepant drug variants not containing COPOVIDONE K25-31

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

ubrogepant drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Allergan Inc	ubrogepant	0023-6498
>Company	>Ingredient	>NDC

ubrogepant drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

ubrogepant drug variants containing MANNITOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Allergan Inc	ubrogepant	0023-6498
>Company	>Ingredient	>NDC

ubrogepant drug variants not containing MANNITOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

ubrogepant drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Allergan Inc	ubrogepant	0023-6498
>Company	>Ingredient	>NDC

ubrogepant drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

ubrogepant drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Allergan Inc	ubrogepant	0023-6498
>Company	>Ingredient	>NDC

ubrogepant drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STEARYL FUMARATE

ubrogepant drug variants containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Allergan Inc	ubrogepant	0023-6498
>Company	>Ingredient	>NDC

ubrogepant drug variants not containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: VITAMIN E POLYETHYLENE GLYCOL SUCCINATE

ubrogepant drug variants containing VITAMIN E POLYETHYLENE GLYCOL SUCCINATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Allergan Inc	ubrogepant	0023-6498
>Company	>Ingredient	>NDC

ubrogepant drug variants not containing VITAMIN E POLYETHYLENE GLYCOL SUCCINATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.